Header cover image

Global Pharmaceuticals & Biotech Sustainable Track Record

UPDATED Jun 29, 2022

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

107 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
VLSVita Life SciencesAU$1.800%60.0%AU$103.0mn/aPE12.4xn/a3.3%
AFTAFT PharmaceuticalsNZ$3.61-1.1%-19.8%NZ$378.6mNZ$4.40PE19.1xE13.0%n/a
601089Beijing Winsunny PharmaceuticalLTDCN¥21.05n/an/aCN¥10.1bn/aPE29.4xn/an/a
300896Imeik Technology DevelopmentLtdCN¥600.016.4%-24.0%CN¥129.8bCN¥654.22PE121.7xE37.8%0.3%
688767Hangzhou Biotest BiotechLtdCN¥61.66-4.7%n/aCN¥6.6bn/aPE6xn/a4.9%
NOVNNovartisCHF81.193.8%-3.8%CHF176.3bCHF90.37PE7.6xE2.7%3.6%
JNJJohnson & JohnsonUS$176.990.7%7.4%US$465.7bUS$187.28PE23.5xE4.4%2.6%
MRKMerckUS$92.513.8%19.0%US$233.9bUS$96.59PE16.8xE11.8%3.0%
REGNRegeneron PharmaceuticalsUS$597.621.8%7.0%US$64.4bUS$679.24PE8.1xE-3.2%n/a
SOHOSoho Global HealthRp6,075.001.3%21.5%Rp7.7tn/aPE13.7xn/a3.2%
500680Pfizer₹4,087.95-0.6%-28.9%₹187.0b₹5,201.25PE30.5xn/a0.9%
MEGAMega Lifesciences฿50.502.5%33.8%฿44.0b฿57.03PE19.8xE6.6%2.7%
BETABeta Drugs₹709.3516.2%114.5%₹6.8bn/aPE37.3xn/an/a
GLAXOGlaxoSmithKline PakistanPK₨124.934.4%-25.7%PK₨39.8bn/aPE7.2xn/a5.6%
2395Shin Nippon Biomedical LaboratoriesJP¥1,978.00-1.8%122.5%JP¥82.3bJP¥3,300.00PE11.6xE0.1%2.0%
CTECryositeAU$0.63-3.1%61.5%AU$30.8mn/aPE26.7xn/a0%
AAgilent TechnologiesUS$117.903.6%-20.2%US$35.2bUS$149.13PE27.9xE9.4%0.7%
300653Yantai Zhenghai BiotechnologyCN¥56.00-0.3%10.1%CN¥10.1bn/aPE56.1xE25.1%1.0%
IBNSINAIBN SINA Pharmaceutical Industry৳296.704.3%20.3%৳9.3b৳370.00PE16.5xS13.9%1.6%
GENOGenovis AB (publ.)kr43.05-4.2%-3.6%kr2.9bkr80.00PE77.4xE55.6%n/a
IPNIpsen€90.054.1%1.9%€7.4b€102.50PE11.5xE0.7%1.3%
538837Jeevan Scientific Technology₹64.0512.9%-29.7%₹980.1mn/aPE6.5xn/a0.8%
OCPHOctober PharmaEج.م159.950%68.3%ج.م959.7mn/aPE8xn/a1.9%
915Shandong Shanda Wit Science and TechnologyCN¥41.35-0.2%53.7%CN¥9.7bn/aPE22.7xE22.1%1.9%
Page 1 of 5